Wells Fargo & Company Pacira Bio Sciences, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 47,383 shares of PCRX stock, worth $838,679. This represents 0.0% of its overall portfolio holdings.

Number of Shares

47,383

Previous 40,798 16.14%

Holding current value

$838,679

Previous $1.19 Million 13.67%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $167,917 - $207,493	6,585 Added 16.14%	47,383 $1.36 Million
Q1 2024 May 10, 2024	BUY	$27.7 - $35.48 $103,099 - $132,056	3,722 Added 10.04%	40,798 $1.19 Million
Q4 2023 Feb 09, 2024	BUY	$26.32 - $34.31 $228,852 - $298,325	8,695 Added 30.64%	37,076 $1.25 Million
Q3 2023 Nov 13, 2023	SELL	$30.68 - $40.09 $381,383 - $498,358	-12,431 Reduced 30.46%	28,381 $870,000
Q2 2023 Aug 15, 2023	SELL	$36.12 - $47.5 $1.38 Million - $1.82 Million	-38,285 Reduced 48.4%	40,812 $1.64 Million
Q1 2023 May 12, 2023	BUY	$35.53 - $43.38 $50,914 - $62,163	1,433 Added 1.85%	79,097 $3.23 Million
Q4 2022 Feb 13, 2023	SELL	$38.19 - $57.45 $81,955 - $123,287	-2,146 Reduced 2.69%	77,664 $3 Million
Q3 2022 Nov 14, 2022	SELL	$51.24 - $58.89 $209,930 - $241,272	-4,097 Reduced 4.88%	79,810 $4.25 Million
Q2 2022 Aug 12, 2022	BUY	$51.49 - $81.64 $219,295 - $347,704	4,259 Added 5.35%	83,907 $4.89 Million
Q1 2022 May 16, 2022	SELL	$60.03 - $76.49 $196,358 - $250,198	-3,271 Reduced 3.94%	79,648 $6.08 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $15.6 Million - $20.3 Million	-325,792 Reduced 79.71%	82,919 $4.99 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $21 Million - $23.6 Million	-384,843 Reduced 48.5%	408,711 $22.9 Million
Q2 2021 Aug 16, 2021	SELL	$59.18 - $69.99 $45.8 Million - $54.2 Million	-774,020 Reduced 49.38%	793,554 $48.2 Million
Q1 2021 May 13, 2021	BUY	$59.31 - $78.82 $10.1 Million - $13.4 Million	169,600 Added 12.13%	1,567,574 $110 Million
Q4 2020 Feb 09, 2021	BUY	$50.47 - $66.26 $29.5 Million - $38.7 Million	584,374 Added 71.83%	1,397,974 $83.7 Million
Q3 2020 Nov 05, 2020	BUY	$51.97 - $63.0 $15.5 Million - $18.8 Million	298,412 Added 57.92%	813,600 $48.9 Million
Q2 2020 Aug 13, 2020	BUY	$30.8 - $52.47 $11.2 Million - $19 Million	362,934 Added 238.37%	515,188 $27 Million
Q1 2020 May 14, 2020	BUY	$28.4 - $50.7 $4.32 Million - $7.72 Million	152,254 New	152,254 $5.11 Million

Others Institutions Holding PCRX

# of Institutions

273

Shares Held

48.4M

Call Options Held

378K

Put Options Held

1.53M

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $811M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pacira Bio Sciences, Inc. Transaction History